Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis

ConclusionsIn addition to decreasing VEGF level, ranibizumab is associated with change of human vitreous protein profile in patients with PDR, in which the differential proteins are involved in immune response, platelet degranulation, complement activation etc., suggesting that the effects of VEGF are involved in these signaling pathways.

http://link.springer.com/10.1186/s12014-018-9187-z

Source: Clinical Proteomics - March 9, 2018 Category: Biochemistry Source Type: research